Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,809
Award facts
- Contract value 100% obligated
- $30,808.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,808.96 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets in quantities of 30, with a firm fixed price structure and an ultimate completion date of January 6, 2026. This non-set-aside competitive award was issued on January 5, 2026, to the prime contractor's corporate office located in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceuticals for military healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's sustained role as a federal pharmaceutical distributor demonstrates its capability to meet competitive procurement requirements for critical medical commodities essential to military operations and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQT5E?
SPE2DR26FQT5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FQT5E worth?
The government has obligated $30,809 on SPE2DR26FQT5E.
Is contract SPE2DR26FQT5E an order under another contract?
Yes. SPE2DR26FQT5E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT5E competed?
The extent of competition for SPE2DR26FQT5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award